Rapalogix Health Announces Publication of Double-Blind Clinical Study Showing Re-Q Longevity Face Serum Improves Skin Firmness, Elasticity, and Biomechanics

Data ReadoutpositiveRe-Q Longevity Face SerumPositive

AI Analysis

Summary

Rapalogix Health published results of a double-blind clinical study in the Journal of Cosmetic Dermatology demonstrating that Re-Q Longevity Face Serum significantly improves skin firmness, elasticity, and biomechanics versus vehicle, with benefits observed as early as Week 2.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Double-blind clinical study showed significant improvements in skin firmness, elasticity, and biomechanics versus vehicle as early as Week 2, with TORC1 pathway suppression demonstrated in human skin models

Importance:4/10

Sentiment:

0.70

clinical datacosmetic dermatologypeer-reviewed publicationskin health

Related Companies

$XAGEW $HIT

Read the original article

Published by PR Newswire Biotech on October 13, 2026 12:00 PM

Read Original